Many cancer cells refractory to radiation treatment and chemotherapy proliferate because of loss of intrinsic programmed cell death (apoptosis) regulation. Consequently, the resolution of these cancers are many times outside the management capabilities of conventional therapeutics. We now report that replication-defective D27 herpes simplex virus (rd D27) triggers apoptosis in three representative transformed human cell lines. Susceptibility to virus-induced cell death is dependent on the abundance and distribution of modified p53 protein in the tumor cells indicating specific targeting of the treatment. Primary human and mouse fibroblast cells that produce modified p53 are resistant to rd D27 killing but not to apoptosis induced by nonviral environmental factors. These results suggest that induction of apoptosis by nonreplicating virus is a feasible genetic therapy approach for killing human cancer cells. Our findings may have important implications in designing novel virus-based anticancer strategies in appropriate animal model systems.
Introduction
Apoptosis, or programmed cell death, is a highly regulated process that is activated during normal development and by various stimuli that disturb cell metabolism and physiology. Characteristic features of apoptosis include apoptotic body formation, cell shrinkage, membrane blebbing, chromatin condensation, and DNA fragmentation. 1 These apoptotic features are the consequence of regulated proteolysis processes. 2, 3 The apoptotic potential of a cell has a profound effect on whether that cell might respond to an environmental stress. In tumor cells, modulation of apoptosis plays a significant role in the progression to malignancy. 4, 5 The central mediator of the cellular response to environmental stresses is the p53 protein and it is a major determinant of whether a cell will undergo apoptosis. 6, 7 For this reason, it is not surprising that mutations in the p53 gene are found in greater than half of all human tumors. 8, 9 Activation of p53 occurs in response to various types of stress, including DNA damage, hypoxia, and oncogenes, and results in increased levels of modified protein. Activated p53 initiates signaling pathways that lead to either cell cycle arrest or apoptosis. 6, 7 The proapoptotic response of p53 to DNA damage introduced by chemotherapeutic agents or radiation is therefore the basis for much of the efficacy of these treatments. 10 Conversely, cells whose p53 has been inactivated are associated with resistance to anticancer drugs. 11, 12 Owing to the cell's innate ability to self-destruct, apoptosis is also an important mechanism of host cell defense against viral infections. Accordingly, several distinct viruses have developed mechanisms to block the premature apoptosis of infected cells. 13 The most likely reason for this is to prevent the cellular apoptosis that occurs as a result of viral infection in order to prolong cell survival so that the production of the viral progeny can be maximized. Wild-type (wt) herpes simplex virus (HSV) triggers apoptosis in cells and then subsequently (between 3 and 6 hpi) stimulates the synthesis of proteins which act to prevent the process from killing the infected cells. 14, 15 HSV replication is tightly regulated and occurs in an ordered cascade. 16 Recombinant HSV strains that initiate but cannot complete their replication cycle because of a reduction in their expression of early and late genes have been defined as apoptotic viruses. 17 In this report, we evaluate the use of a replication-defective (rd) virus as a potential antioncogenic agent based on their ability to trigger apoptosis in transformed human cells.
Results

Viral induction of apoptosis in human tumor cells
Human cervical carcinoma HeLa cells present apoptotic features including cell shrinkage, membrane blebbing, and the formation of apoptotic bodies following infection 18 with a recombinant HSV-1 lacking the essential ICP27 regulatory protein, termed rd D27. HeLa cells contain integrated human papilloma virus (HPV) 18 DNA 19 and express the viral E6 and E7 gene products. 20 While most cell lines derived from cervical carcinomas possess intact genomic copies of p53 and p105 Rb genes, 21 these proteins are inactivated by E6 and E7, respectively. 22, 23 The E6 protein acts to increase the ubiquitindependent degradation of p53 and E7 complexing to p105
Rb results in the release of the transcription factor, E2F, which in turn activates genes involved in cell proliferation. 6, 7, [24] [25] [26] [27] Thus, the consequence of E6 and E7 expression in HeLa cells is the loss of check point control leading to immortalization. Our goal is to determine whether human tumor cells are specifically sensitive to HSV-induced apoptosis (oncoapoptosis) and if p53 inactivation is a determinant of susceptibility.
We treated three human tumor cell lines with the rd D27 strain for 16 h (multiplicity of infection (MOI)¼10) and defined apoptosis by the appearance of death factor processing. 15 Human epidermoid HEp-2 cells were derived from a patient with laryngeal carcinoma. 28 Human 143B cells are an osteogenic murine sarcoma virustransformed line 29 that was selected in bromodeoxyuridine for the loss of thymidine kinase. 30 Infection of HeLa, HEp-2, and 143B cells with rd D27 led to apoptosis, since PARP and procaspase-3 processing was detected, while wt HSV or mock infection did not ( Figure  1a) . As an additional control, rd D3 infection of HEp-2 cells was also performed. These results indicate that at least two separate rd HSV strains trigger apoptotic death in transformed human cells. Based on our current model for defining apoptosis during HSV infection, 14, 17 we conclude that these rd HSV viruses are unable to prevent the induced cell death process from killing the infected cells, leading to the state of viral oncoapoptosis.
HEp-2 cells are phenotypically similar to HeLa cells 28 but have not been as extensively studied. While HPV30 has been isolated from human laryngeal carcinoma tissue specimens, 31 there is currently no evidence that HEp-2 cells contain integrated papilloma virus DNA. To assess whether HEp-2 cells contain functional p53, we UV irradiated the cells 32 and measured immune reactivities of p53 and death factors (Figure 1b) . We detected activation of caspase-3 as early as 30 min following UV treatment (Figure 1b , compare lanes 1 and 2) and PARP processing was observed beginning at 3 h post-treatment (Figure 1b, lane 6) . While the molecular mechanism of this early caspase-3 activation remains unknown, a similar kinetic pattern of death factor processing was observed in these cells following wt HSV infection. 15 Thus, in both of these systems, loss of caspase-3 seems biphasic; initially, there is a reduction of caspase-3 in the UV-treated or infected cells compared to that of control cells, followed by a complete processing at later times. The processing of both of these death factors increased up to the latest time point tested, 6 h post-treatment. In HEp-2 cells analyzed immediately after treatment, we detected two forms of p53, with the faster migrating form being the more abundant form (Figure 1b, lane 1) . The detection of multiple forms of p53 is consistent with its ability to undergo post-translational modifications. 7 As the time following UV treatment increased, the distribution of the two forms changed and the slower migrating form became more abundant (compare lanes 1 and 2 with 7 and 8). These findings indicate that HEp-2 cells possess full-length genomic copies of the p53 gene and suggest that the distribution of p53 changes in response to UV irradiation. However, even after stimula- Apoptosis in cancer cells triggered by replication-defective D27 virus M Aubert and JA Blaho tion by UV, the amount of p53 in the cells did not dramatically increase, implying that these cells likely contain a function that may facilitate the degradation of p53. Based on the phenotypic similarities between HEp-2 and HeLa cells, these results suggest that the p53 levels in the two cell lines may also be equivalent. Our next goal was to compare directly the amounts of the p53 present in the human tumor cells that were susceptible to oncoapoptosis. We probed equal amounts of HEp-2, 143B, and HeLa cell extracts for their immune reactivities with an anti-p53 antibody that recognizes the human, monkey, and mouse forms of the protein ( Figure  1c) . As a control, immortalized African green monkey kidney Vero fibroblasts were also analyzed. In our initial study, we reported that Vero cells do not show signs of apoptosis, including cell shrinkage, membrane blebbing, and chromatin condensation, after 24 h of infection with either rd D27 or wt HSV, in the presence or absence of cycloheximide (CHX). 18 In addition, we included human embryonic kidney 293 cells, transformed by exposing primary cells to fragments of sheared adenovirus type 5 DNA, 33 as well as primary mouse embryo fibroblasts (MEF). The 293 cells synthesized the highest level of p53 and the protein was equally distributed between a fast and a slow migrating form. This observation is consistent with the fact that the E1a protein present in the 293 cells functions to activate p53. 34 The slower migrating, modified form of p53 predominated in the Vero and MEF fibroblast cells. In contrast, the fast migrating form of p53 predominated in the HEp-2, 143B, and HeLa cells ( Figure 1c , lanes 2-4). These results indicate that the cells (HEp-2, 143B, HeLa) that are sensitive to apoptotic death by rd D27 (Figure 1a ) synthesize p53 protein, which is markedly undermodified. While the amounts of p53 detected in the HEp-2 and HeLa cells were substantially reduced compared to that in the 293 cells, the amount in the 143B cells was equivalent to the fast migrating form in the 293 cells. Additionally, at least two of the sensitive tumor cell lines tested (HEp-2 and HeLa) produced reduced levels of p53 relative to that observed with the 293 cells. In our initial study, we observed that 143B cells show much more pronounced apoptotic features (cell shrinkage and membrane blebbing) following rd D27 infection compared to those of HeLa and HEp-2 cells. 18 Together, these findings imply that the levels of undermodified p53 detected in cells may determine whether rd D27 causes apoptosis. Our findings also suggest that cells whose p53 has been inactivated are susceptible to killing via a viral oncoapoptotic mechanism.
Primary fibroblasts are resistant to viral oncoapoptosis but not death factor-or death receptor-mediated apoptosis
The results in Figure 1 indicate that monkey and mouse fibroblasts accumulate predominantly modified p53. As stated above, the Vero fibroblasts appear resistant to the induction of apoptosis by HSV when analyzed at 24 h postinfection. 18 To determine whether MEF cells are also insensitive, we infected them with either wt HSV or rd Figure  2b ). The rd D27 produced wt levels of viral immediate early ICP4 and early TK proteins with reduced amounts of the late gD protein and undetectable levels of the true late gC. This pattern of viral protein accumulation is essentially identical to that observed following rd D27 infection of Vero cells. 18 Conversely, these results are in contrast to that observed with rd D27 infected human HEp-2 tumor cells where the synthesis of all classes of viral proteins are significantly reduced. 18 To assess whether HSV triggers apoptosis in infected MEF, we documented cell morphologies by phasecontrast microscopy and visualized condensed nuclei following staining with a fluorescent Hoechst dye ( Figure 3 ). Cells were also treated with staurosporine (STS) or TNF plus CHX for 16 h to determine whether these environmental agents could induce apoptosis in primary mouse fibroblasts. The concentrations of these environmental agents used in this study are sufficient to stimulate cell death in the human HEp-2 cells. 18 Consistent with the results in Figure 2 , wt HSV infection led to the appearance of large, rounded cells showing classic 18 cytopathic effect (Figure 3a ). In contrast, MEF cells infected with the rd D27 had a morphology identical to mock-infected cells. Few, if any, cells with condensed nuclei were detected following infection with either HSV strain. Based on these results, we conclude that rd D27 is unable to trigger apoptosis in primary mouse fibroblasts within the time frame utilized in our study. Treatment of the MEF cells with either STS or TNF plus CHX lead to a significant number of small apoptotic cells that contained condensed chromatin (Figure 3b ). These findings indicate that primary MEF cells are susceptible to the induction of cell death via both the death receptor and the death factor pathways. Taken together, the results in Figures 2 and 3 show that the lack of cytopathic effect in MEF cells after rd D27 infection is because of the inability of this mutant virus to complete its replication cycle. Since the primary MEF cells contain predominantly modified p53 (Figure 1) , we conclude that the functional status of p53 may play a role in determining whether cells are susceptible to killing by an oncoapoptotic virus.
The transformed cell lines we analyzed above were of human origin. Thus, it was necessary to confirm our MEF cell results using a primary human cell line. We assessed the p53 status, the susceptibility of rd D27 infection (16 h postinfection, MOI¼10), and the ability to undergo apoptosis of primary human foreskin fibroblast (HFF) cells ( Figure 4) . As an additional control, rd D3 infection of HFF cells was also performed. The p53 protein detected in the rd D27, rd D3, and wt HSVinfected HFF cells was identical to that observed in mock-infected cells (Figure 4a ). Consistent with observations using MEF cells, we found reduced levels of the late gD protein with no true late gC production during rd D27 or rd D3 infection compared to that of wt HSV. This result demonstrates the inability of these rd HSV strains to complete their replication cycles in HFF cells. However, we detected similar amounts of caspase-3 following mock, rd D27, rd D3, and wt HSV infection indicating that little to no death factor processing had occurred. We next performed ethidium bromide staining of low molecular weight DNA fragment preparations. While some DNA laddering was detected with rd D27 and rd D3, it was at a level similar to that of wt HSV and was not significant compared to mock-infected cells (Figure 4b ). We detected DNA fragmentation that migrated as a smear after treatment with STS. Interestingly, the treatment with TNF plus CHX resembled the infected cells suggesting that HFF cells may be somewhat resistant to this environmental stimulator. Finally, we stained the infected and treated HFF cells with Hoechst DNA dye and visualized cellular and nuclear morphologies by fluorescence and phase-contrast microscopy (Figure 4c ). We detected little to no condensed chromatin following rd D27 or rd D3 infection. The TNFplus-CHX-treated cells resembled the infected cells. Only the STS-treated cells showed features indicative of apoptosis. As these infections were for 16 h, little classical CPE was observed with wt HSV. However, the wt HSV cells clearly showed signs of infection when Figure 4a . Based on these findings, we conclude that the rd D27 and rd D3 strains cannot trigger apoptosis in primary human fibroblast cells under these experimental conditions. Despite this lack of evidence for apoptosis, we cannot exclude the possibility that these cells might eventually die in response to these treatments as they are primary cells in culture.
Adenoviral DNA-containing human kidney 293 cells are resistant to apoptosis
The results above indicate that cells whose p53 is undermodified are susceptible to apoptosis triggered by rd D27 and rd D3, while those which accumulate lower electrophoretic mobility forms of p53 are resistant.
To confirm the prediction that the amount of modified p53 present in a given cell is an accurate indicator of whether the cell will be killed by rd D27, we analyzed 293 cells ( Figure 5 ). Human 293 cells were infected for 16 h with rd D27, rd D3, and wt HSV strains (MOI¼10) in the presence or absence of the translation inhibitor CHX. This inhibitor was added as a control since HEp-2 cells infected with wt HSV or rd D27 in the presence of CHX are apoptotic. 15, 18 CHX addition during HSV infection has been reported to stimulate the expression of viral IE genes. 35 We included STS treatment in this study as an additional positive control for the induction of apoptosis. 15 We performed immunoblots for the PARP and caspase-3 death factors, as well as for the p53 protein following the infections and treatments (Figure 5a ). Unprocessed PARP and caspase-3 were detected in all cases indicating that the cells did not undergo apoptosis. Consistent with the results in Figure 1 , approximately equal amounts of the two forms of p53 were detected under all conditions. Our results indicate that these infection and treatment conditions are insufficient to trigger apoptosis in human 293 cells.
To confirm that 293 cells are resistant to apoptosis, we either UV irradiated the cells, serum starved them, and treated them for 16 h with TNF plus CHX or a double dose of STS prior to performing immunoblots for p53 and death factors (Figure 5b) . Even under this diverse array of stimulation, no signs of apoptosis were detected. Approximately equal amounts of the two forms of p53 were detected under all conditions. There appeared to be a slight increase in the total amount of p53 following UV treatment, suggesting that this irradiation may have induced the synthesis of p53. These results indicate that 293 cells are unable to be induced to undergo apoptosis. As indicated earlier, human 293 cells are derived from primary embryonal kidney cells and were transformed by DNA from adenovirus type 5. 33 While the E1a protein in 293 cells activates and stabilizes p53, apoptosis is prevented through the action of the E1b proteins. 34, 36 The E1b 19 kDa protein functionally substitutes for the activity of Bcl-2 while the E1b 55 kDa binds p53 and inhibits its function. Based on these results, we conclude that cells that contain viral antiapoptotic activities, such as those conferred by the adenovirus E1b region, are resistant to rd D27-or rd D3-induced cell death.
Finally, we performed immunoblots for various viral proteins following wt HSV and rd D27 infection of the 293 cells (Figure 5c ). As we observed with HFF and MEF cells (Figures 4 and 2) , all viral proteins were detected with wt HSV, while reduced gD and no gC was made by the rd D27. Identical results were obtained using the related 293T cells (data not shown). Taken together, we conclude that human 293 cells are resistant to the induction of apoptosis by rd D27. However, in contrast to primary HFF and MEF cells, 293 cells are also resistant to the induction of apoptosis by a wide variety of environmental stimulators. These findings support our hypothesis that cells which produce a significant amount of slow migrating p53 are unable to be killed by HSVinduced apoptosis.
Discussion
Cancer therapies by genotoxic agents rely on the induction of apoptosis and are limited in cells defective 
10-12 HSV has a broad host range and is able to initiate infection in cells derived from diverse tissue types. The goal of this study was to determine whether viral infection was a feasible approach for killing cultured human tumor cells. We show that three human tumor cell lines are susceptible to death by rd D27-mediated apoptosis. We propose the term oncoapoptosis to describe this viral induction of programmed cell death in tumor cells. The common feature among the susceptible cells was that they accumulated undermodified p53. This finding suggests that the modified state of p53 may be a marker for susceptibility to apoptosis triggered by rd D27. In addition, the levels of p53 that accumulated in the sensitive cells were much less than that in the resistant cells. It is conceivable that cells in which p53 has been inactivated by a deletion or frameshift mutation would also be susceptible to rd D27 killing. The fact that primary HFF and MEF cells are resistant supports the model that cells which can accumulate modified p53 are unable to be triggered to undergo apoptosis by rd D27. It must be recognized that there are many essential genes of HSV, for which rd viruses have been constructed and are blocked at different stages of the viral replication cycle. Thus, while this study focuses on the rd D27 virus, it is possible that not all rd viruses may cause oncoapoptosis. We are currently analyzing other rd HSV strains, including additional studies using rd D3, to help further our understanding of the roles of the various HSV IE gene products in HSV-mediated toxicity and apoptosis.
It has been proposed that apoptosis functions to limit virus spread by preventing viral replication, thus saving other cells from infection. 13 HSV has developed a mechanism to counteract this antiviral cell death process.
14 Cells infected with wt HSV do not show features of apoptosis because infected cell proteins produced between 3 and 6 hpi, termed the apoptosis 'prevention window', 15 prevent the process from killing the cells. Thus, human HEp-2 cells infected wt HSV plus the addition of CHX at the time of infection are executed by apoptosis. 18, 37, 38 While it had been shown by this lab and others that wt HSV infection could block apoptosis induced by extracellular stimulants such as TNFa, anti-FAS antibody, CHX, STS, ceramide, osmotic shock using sorbitol or ethanol, and hyperthermia, 15, 18, [37] [38] [39] [40] [41] we demonstrated that infected cell proteins produced during the apoptosis prevention window inhibited cell death triggered by STS and sorbitol. 15 Although most recent efforts have focused on identifying viral gene products involved in apoptosis prevention during infection, 15, 17, 18, 37, [42] [43] [44] little is known of the mechanism of induction of the process. We are currently expanding our studies on apoptosis induction to include a diverse array of cells derived from various solid human tumors to extend our initial findings presented in this report.
Recent interest has focused on the development of rd HSV strains for use as vectors in long-term gene delivery strategies (reviewed in Fink et al 45 and Goins et al 46 ). Early-generation rd HSV vectors were devoid of ICP4 and prone to cell cytotoxicities. 47, 48 It has not been determined whether these toxicities are in fact due to apoptosis. Development of vectors containing deletions in one or more IE gene led to reduced cytotoxicities. [49] [50] [51] [52] [53] The establishment of a rd HSV strain devoid of all IE genes yielded a nontoxic vector. 54 Evidence has mounted that points to the viral IE ICP0 protein as a major cause of these toxicities, [55] [56] [57] most likely because of its ability to inhibit cell cycle progression. 58, 59 The common feature of all of these vectors is that they are deleted for ICP4 and it has long been known that IE gene expression is elevated during infection in the absence of ICP4. [60] [61] [62] [63] [64] We are currently investigating whether levels of ICP0 exist during our rd D27 infections that may have secondary toxic effects.
Other 72 We present data showing an alternative and novel strategy for the selective killing of tumor cells that we have termed viral oncoapoptosis. In our system, a virus that is unable to complete its replication cycle initiates an abortive infection that triggers tumor cells to undergo apoptosis. These results may have significant implications in the development of future anticancer therapies.
Materials and methods
Cells and viruses
All cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 5% fetal bovine serum (FBS). Human larynx epidermoid carcinoma HEp-2, 28 epithelial cervical carcinoma HeLa S3, 73 osteosarcoma 143B, 74 and African green monkey kidney Vero 75 cells were obtained from the American Type Culture Collection (Rockville, MD, USA). Adenovirus type 5 transformed human primary embryonal kidney 293 33 and SV40 T antigen expressing 293T cells (originally obtained from the ATCC) were provided by A Garcia-Sastre (this institution). Transformed 293 cells contain an integrated portion of the Adenovirus 5 early region 1 that facilities the synthesis of viral E1a and E1b (55 and 19 kDa) proteins in these cells. 76 Primary HFF cells were generously provided by Timothy O'Connor (City of Hope, Duarte, CA, USA) and passaged in DMEM supplemented with 10% FBS; all experiments were performed using passages 3-6 of the HFF cells. Primary C57B mouse embryo fibroblast cells were generously provided by T McGaha (this institution). Cell monolayers were infected at an MOI of 10 PFU/cell and the infections were maintained at 371C in DMEM with 5% newborn calf serum (NBCS) for 16 h. KOS1.1 virus 77 is the wt HSV (KOS) used in this study and vBSD27 virus (generous gifts of S Silverstein) is a recombinant HSV (rd D27) in which the ICP27 gene was replaced by the bgalactosidase gene. 78 CgalD3 virus 47 is a recombinant HSV (rd D3) carrying a 4.6 kb insertion of an HCMV Apoptosis in cancer cells triggered by replication-defective D27 virus M Aubert and JA Blaho promoter-lacZ gene within the ICP4 coding region (obtained from T Freidmann, UCSD).
UV irradiation of cells
The technique for UV treatment of infected cells is a modification of our protocol described previously. 15 Confluent HEp-2 cells grown in a 35 mm dish (Falcon) in 5% NBCS were placed on ice at a distance of 10 cm from a germicidal lamp (Model MR-4 -60 Hz, George W Gates and Company, Franklin Square, NY, USA). Cells were exposed to UV light for 5 min. Following UV treatment, cells were returned to 371C and incubated for varying times up to a maximum of 6 h, prior to preparing whole-cell extracts.
Biochemical (environmental) induction of apoptosis
Cell apoptosis was induced by the addition of STS (Calbiochem, San Diego, CA, USA) to the medium at a final concentration of either 1 or 2 mM. Cells were maintained in the presence of STS for 16 h. TNFa (Sigma) was added directly to medium at a final concentration of 10 ng/ml in combination with CHX (Sigma) at a final concentration of 10 mg/ml for 16 h. We detected oligomeric DNA laddering using fluorescence enhancement of ethidium bromide bound to low molecular weight DNA separated in an agarose gel as described. 18 
Extraction of cells and denaturing gel electrophoresis
Whole extracts of cells were obtained as previously described. 15, 18 Protein concentrations were measured using a modified Bradford assay (Biorad) as recommended by the vendor. Equal amounts of infected cell proteins (50 mg) were separated in denaturing 15% DATD-acrylamide gels and electrically transferred to nitrocellulose membranes in a tank apparatus (Biorad) prior to immunoblotting with various primary antibodies. Unless otherwise noted in the text, all biochemical reagents were obtained from Sigma. Nitrocellulose was obtained directly from Schleicher and Schuell. Prestained protein molecular weight markers were purchased from Life Technologies.
Immunological reagents
Immunoblotting experiments were performed to detect cellular apoptotic proteins using mouse anticaspase-3 monoclonal antibody (1:1000; Transduction Laboratories Inc.) and mouse anti-PARP monoclonal antibody (1:2000; Pharmingen) as described previously. 15 Secondary (goat) anti-rabbit, anti-mouse, and (rabbit) anti-goat antibodies conjugated with alkaline phosphatase (1:1000) were purchased from Southern Biotech (Birmingham, AL, USA) and secondary (goat) anti-mouse conjugated to horseradish peroxidase (1:1000) was from Amersham. Anti-p53 (14211A) monoclonal antibody was obtained from Pharmingen.
Microscopic analyses and computer graphics
Infected cell phenotypes were documented by phasecontrast light microscopy using an Olympus CK2/PM-10AK3 system with an attached 35 mm camera. For analyses of chromatin condensation, cells were grown and infected (as described above) in a 35 mm plate. At 16 hpi, the cells were incubated with the DNA dye Hoechst 33258 (Sigma) at a final concentration of 5 mg/ml in PBS for 15 min at 371C. Immunoblots, autoradiograms, and 35 mm slides were digitized at 600-1200 dots per inch resolution using an AGFA Arcus II scanner linked to a Macintosh G3 PowerPC workstation. Raw digital images, saved as tagged image files (TIF) using Adobe Photoshop version 5.0, were organized into figures using Adobe Illustrator version 7.1.
